BREAKING
Home » Posts Tagged "Lyme vaccine"

Lyme disease: mRNA vaccine developed that provides protection against Borrelia burgdorferi in pre-clinical research

By

NewsDesk @bactiman63 An experimental mRNA vaccine provides protection in preclinical animal models against infection from Borrelia burgdorferi, the bacteria that causes Lyme disease, according to new...

ticks

mRNA Lyme vaccine shows promise

By

By NewsDesk  @bactiman63 Yale University researchers have developed a novel vaccine that in guinea pigs offers protection against infection by the bacterium that causes Lyme disease and may also combat...

Lyme Disease vaccine candidate: Final Phase 2 study initiated

By

Valneva SE and Pfizer Inc. announced Monday the initiation of study VLA15-221. The VLA15-221 study builds on previous positive Phase 2 studies, incorporates new dose regimens and is anticipated to be the...

Valneva announces plans to accelerate pediatric development of its Lyme vaccine candidate

By

By NewsDesk  @bactiman63 Specialty vaccine company, Valneva SE, announced yesterday its plans to accelerate pediatric development of its Lyme vaccine candidate, VLA15, in collaboration with Pfizer Inc.,...

Lyme disease vaccine: Valneva reports positive second Phase 2 data

By

By NewsDesk  @bactiman63 Specialty vaccine company, Valneva, today announced positive initial results for its second Phase 2 study (VLA15-202) of Lyme disease vaccine candidate VLA15. Compared to study...

Lyme disease vaccine: Valneva announces positive initial Phase 2 study results

By

 Valneva SE, a specialty vaccine company focused on prevention of diseases with major unmet needs, today announced positive initial results for its first Phase 2 study (VLA15-201) of Lyme disease vaccine...

Lyme disease vaccine: Valneva announces collaboration with Pfizer

By

Valneva SE, a specialty vaccine company, and Pfizer Inc. today announced a collaboration to develop and commercialize Valneva’s Lyme disease vaccine candidate VLA15, which is currently in Phase 2 clinical...

Lyme vaccine: Valneva completes recruitment for Phase 2 studies

By

Valneva SE, a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, Monday announced that it has completed patient recruitment of the Phase 2 studies for...

Lyme and other tickborne diseases: ‘We need a national public-private strategy’

By

A week ago, an opinion piece was published in Newsday entitled, A bold plan against tick borne disease, which states that a national public -private strategy is needed. Joining me today is the co-author...

Lyme disease vaccine candidate: Initiation of second study of Phase 2 clinical development

By

Biotech and vaccine development company, Valneva announced today the initiation of the second study of Phase 2 clinical development for its leading, unique Lyme disease vaccine candidate VLA15. The overall...